Homebiotech

biotech

biotech

Revvity to acquire Human Cell Design

Jim Cornall - September 16, 2026

biotech

Engineered immune cells trial to fight colorectal cancer approved

Jim Cornall - September 16, 2026

biotech

Elix and Axcelead DDP to collaborate on targeted protein degrader discovery

Jim Cornall - September 16, 2026

biotech

Lotus Neuro launches to deliver therapies across blood-brain barrier

Jim Cornall - September 15, 2026

biotech

New drug candidate shows promise as brain cancer treatment

Jim Cornall - May 19, 2026

biotech

Blood test that detects tumour DNA could help guide treatment when cancer has spread

Jim Cornall - May 19, 2026

biotech

Hereditary epilepsy treatment

Jim Cornall - May 18, 2026

biotech

Myelin, a new brain regulator

Jim Cornall - May 18, 2026

biotech

Lab-designed molecule offers promising alternative for coeliac disease

Jim Cornall - May 18, 2026

biotech

Base to Base biotech podcast 59: DIA helping biotech thrive, and Gorlin syndrome

Jim Cornall - May 15, 2026

biotech

Positive data from AMD treatment trial

Jim Cornall - May 14, 2026

biotech

‘Hidden switch’ in immune cells helps kill deadly fungus

Jim Cornall - May 14, 2026

1...232425...100 Page 24 of 100

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Revvity to acquire Human Cell Design

Jim Cornall - September 16, 2026 0

Revvity, Inc. has entered into a definitive agreement to acquire Human Cell Design (HCD), a France-based biotechnology company specialising in human cell models and...

Engineered immune cells trial to fight colorectal cancer approved

biotech Jim Cornall - September 16, 2026 0

Elix and Axcelead DDP to collaborate on targeted protein degrader discovery

biotech Jim Cornall - September 16, 2026 0

Lotus Neuro launches to deliver therapies across blood-brain barrier

biotech Jim Cornall - September 15, 2026 0

Antibody targeting TSLP achieves positive results in asthma study

biotech Jim Cornall - September 15, 2026 0